PROTAC RIPK1 Degrader-1
Product Specifications
Target
PROTACs|||RIP kinase
Related Pathways
NF-?B|||Apoptosis|||PROTAC
Bioactivity
PROTACRIPK1Degrader-1 is a selective RIPK1 PROTAC degrader. This compound degrades RIPK1 in various cancer cell lines, such as A375 and B16F10 cells. It enhances the anticancer effects of radiotherapy in both syngeneic and humanized mouse models. PROTACRIPK1Degrader-1 is applicable for research in cancers like melanoma.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/390881992805761136/T212277
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6213399-01 0.1 mL
PSMB2 (Proteasome Subunit beta Type-2, Proteasome Component C7-I, Macropain Subunit C7-I, Multicatalytic Endopeptidase Complex Subunit C7-I, MGC104215, MGC126885) (MaxLight 550)
Ask
View Details MBS6213399-02 5x 0.1 mL
PSMB2 (Proteasome Subunit beta Type-2, Proteasome Component C7-I, Macropain Subunit C7-I, Multicatalytic Endopeptidase Complex Subunit C7-I, MGC104215, MGC126885) (MaxLight 550)
Ask
View Details 
AP9C732-01 1 mg
Recombinant Goat Insulin-Like Growth Factor I (IGF1), N-His and C-Myc
Ask
View Details AP9C732-02 100 µg
Recombinant Goat Insulin-Like Growth Factor I (IGF1), N-His and C-Myc
Ask
View Details 
AP9C732-03 20 µg
Recombinant Goat Insulin-Like Growth Factor I (IGF1), N-His and C-Myc
Ask
View Details